Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?

Using folic acid (FA) as placebo complicates the interpretation of the findings of few RCTs evaluating safety and efficacy of hydroxychloroquine prophylaxis in COVID-19. FA is found to bind to furin-protease and spike: ACE2 interface of SARS-CoV-2. In clinical studies, FA level was lowest among seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Hardeep, Sarma, Phulen, Bhattacharyya, Anusuya, Prajapat, Manisha, Kumar, Subodh, Prakash, Ajay, Medhi, Bikash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896118/
https://www.ncbi.nlm.nih.gov/pubmed/33662863
http://dx.doi.org/10.1016/j.mehy.2021.110539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896118/
https://www.ncbi.nlm.nih.gov/pubmed/33662863
http://dx.doi.org/10.1016/j.mehy.2021.110539

Ejemplares similares